AstraZeneca in Gothenburg

  • GOTHENBURG
  • SWEDEN
Where world leading science becomes the potential for producing life changing medicines

Home / Our company / Gothenburg


Our people support the entire life cycle of medicines. That’s everything from idea generation through discovery research, via early and late-stage clinical development, to pilot scale manufacturing, distribution, global commercialisation, and product maintenance.

Learn more about our Gothenburg site and why we go to work in the video below.


Gothenburg key facts


3,000

Employees

41%

Of our employees are born in another country

55%

Of our line managers are female



Where innovation meets patient impact

Our scientists are tackling some of the world's most complex diseases across cardiovascular, renal, metabolic, respiratory and immunology research. Gothenburg's unique strength lies in its ability to bring together the expertise, technology and capabilities needed across the entire medicine journey, from early discovery to global patient delivery.

This connected approach helps us advance pioneering science, accelerate innovation and bring potentially life-changing medicines to patients faster.



Enabling clinical trials worldwide


Gothenburg is home to AstraZeneca's largest unit for manufacturing clinical supplies. Here, we produce investigational medicines for clinical trials across all therapy areas, helping bring potential new treatments to patients around the world.

Our state-of-the-art facilities manufacture oral, parenteral and inhaled medicines, supported by advanced packaging, labelling and global distribution capabilities. By combining scientific expertise, digital technologies and innovative manufacturing processes, we help accelerate the development of life-changing medicines.


Flexible infrastructure for world-leading science

At AstraZeneca Gothenburg, our scientific leadership is supported by a unique and flexible research infrastructure. Our state-of-the-art activity-based laboratories bring together expertise and advanced capabilities across chemistry, automation, imaging, mass spectrometry, cell sciences and sample handling.

Designed to foster collaboration and adapt to evolving scientific priorities, our connected laboratories and workspaces enable expertise, technology and ideas to come together seamlessly. This flexible approach optimises resources, supports scientific excellence across disciplines and helps accelerate innovation across the medicine life cycle.




Our Gothenburg Culture 



Culture

  • Our employees come from different cultures, backgrounds and disciplines, creating a vibrant international environment where diverse perspectives fuel innovation and scientific discovery. 
  • We foster a culture of curiosity, collaboration and inclusion, empowering people to challenge conventional thinking, explore new possibilities and turn bold ideas into breakthroughs for patients. 


Collaboration

  • We believe collaboration is essential to advancing science and accelerating innovation. Through partnerships across industry, academia and healthcare, we combine expertise, technologies and perspectives to help address some of the world's most complex health challenges. 
  • As a co-founder and active partner in leading innovation initiatives, including BioVentureHub, GoCo Health Innovation City and AI Sweden, we help strengthen Sweden's life science ecosystem and create new opportunities for scientific discovery and growth.


Community

  • We are committed to making a positive impact beyond our own operations, working with partners across education, healthcare and local communities to inspire the next generation and support healthier lives. 
  • Through partnerships, mentorship and employee volunteering, we help strengthen the communities where we live and work.





100%

electricity use from renewable sources and renewable heat

1,4 billion SEK

investment in partnership commitments with academic institutions since 2010

99%

reduction of the Gothenburg site's greenhouse gas emissions (scope 1 and 2) since 2015




Gothenburg brings together exceptional people, pioneering science and cutting-edge technologies in a uniquely connected environment. By combining decades of expertise with advances in AI, automation and data science, we are accelerating innovation and creating new possibilities for patients.

Regina Fritsche-Danielson Senior Vice President and Head of Research & Early Development, Cardiovascular, Renal and Metabolism (CVRM), AstraZeneca